Free Trial

Opens lower

GILTS
Gilts open 19 ticks down.
  • U.S. firm Novavax showed trials in the U.K 89.3% efficacy, after 2 doses, including 85.6% against the new UK variant.
  • The one caveat is that a trial in South Africa, showed that it had only 50% against the SA strain.
  • GBP is mixed in G10 this am, with some weakness in Cable, mainly led by better EURGBP buying

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.